Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Immuno Biotech presents GcMAF Research Papers on fighting Cancer and Autism treatment at International Conferences in the USA and Dubai

Immuno Biotech presents GcMAF Research Papers on fighting Cancer and Autism treatment at International Conferences in the USA and Dubai

Ratings: (0)|Views: 5 |Likes:

GcMAF helps fight Autism and Cancer by rebuilding body's immune system.

GcMAF helps fight Autism and Cancer by rebuilding body's immune system.

More info:

Published by: Star One Public Relations on Feb 08, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

08/07/2014

pdf

text

original

 
Immuno Biotech presents GcMAF Research Papers on fightingCancer and Autism treatment at International Conferences in theUSA and Dubai
GcMAF helps fight Autism and Cancer by rebuilding body's immune system.Guernsey, UK (February 8, 2013)
-- On February 1, 2013, in simultaneouspresentations at the Immunology Conference in San Diego, California and at theInternational Cancer Conference at the University of Sharjah in the United ArabEmirates, Guernsey-based company, Immuno Biotech Ltd. presented its latestresearch paper onGcMAF. The presentation was entitled "Multifacetedimmunotherapeutic effects of GcMAF on human breast cancer cells" and was co-authored by Lynda Thyer, one of Immuno Biotech's biomedical scientists, andProfessor Ruggiero of the University of Florence, Italy.It included videos, taken through high powered microscopes in their laboratory,showing cancer cells being destroyed using GcMAF molecules, which they hadextracted from human blood. GcMAF is a key part of the human body's immune systemand the body's own production is often reduced as part of the attacking mechanism of diseases and cancer.Lynda Thyer presented to an audience of over 200 American scientists at theImmunology Conference and was congratulated on the content by other scientistsafterwards, in particular the videos which are a world first.David Noakes, the CEO of Immuno Biotech, presented at the International Cancer Conference and was told afterwards that his presentation was the most easilyunderstood in the three days of the conference. The University was sufficientlyimpressed to ask Immuno Biotech to provideGcMAFfor use with the University's hugelibrary of 2,000 cancer cell lines, so that GcMAF can be tested with many more types of cancers in the laboratory. This will extend the knowledge of the effectiveness of GcMAFwhich has mainly been used in human trials so far. The University of Sharjah is one of the world leaders in cancer and molecular research, with state-of-the-art facilitiesattracting resident professors from all over the world.David Noakes will also be presenting Immuno Biotech's "GcMAF in Autism" researchpaper at the International Dubai Autism Conference, which was based on a US trialwith 1500 autistic children. Most of them had significant reductions in autistic symptomsindicating that infection is playing a role in some forms of autism. The company hasalready been asked to supply GcMAF for three Dubai autism trials, on top of the 1,500

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->